Cannabidiol has antipsychotic effects. The exact cause for these effects is not clear. But cannabidiol seems to prevent the breakdown of a chemical in the brain that affects pain, mood, and mental function. Preventing the breakdown of this chemical and increasing its levels in the blood seems to reduce psychotic symptoms associated with conditions such as schizophrenia. Cannabidiol might also block some of the psychoactive effects of delta-9-tetrahydrocannabinol (THC). Also, cannabidiol seems to reduce pain and anxiety.
To make this more concrete, let’s use an example here. This is a high-CBD hemp oil product made from industrial hemp. It has a concentration of CBD between 18% and 24%. This means that it has 18%–24% parts CBD dissolved in the actual oil, which is composed by other substances. So 18%–24% is pure CBD, and the rest are hemp oil extracts and other fatty acid substances.
The only proven to be good for you range of CBD products that support your health and general well-being. No other CBD product on the market can make these claims or even suggest that their products are good for your health and well-being. Each of our formulations is backed up by substantial scientific data. This has enabled us to present our products with these claims that have been certified and approved for use by the European Food Safety Authority. This really is the first and only well-being product on the market.
They’re just saying if you haven’t already been introduced to nicotine, why start? Nicotine is a habit forming drug and vaping has Nicotine in it’s Vape juices… but if you intend on Vaping @ 0% Nicotine, then you are Right, it wouldn’t be a problem… but sometimes temptation for kids in school for instance, Vaping for leads to adding that nicotine to the equation…
Nabiximols (brand name Sativex) is a patented medicine containing CBD and THC in equal proportions. The drug was approved by Health Canada in 2005 for prescription to treat central neuropathic pain in multiple sclerosis, and in 2007 for cancer related pain. In New Zealand, Sativex is "approved for use as an add-on treatment for symptom improvement in people with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other anti-spasticity medication."